Clinical Trial Update: MoleGazer Development Feasibility Study [NA]

View source ↗

Summary

A feasibility study named MoleGazer led by Oxford University Hospitals NHS Trust is in development for melanoma and benign moles, with status showing active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanocytic Nevus
• Melanoma

Snippet

Sponsor: Oxford University Hospitals NHS Trust | Conditions: Melanoma (Skin), Moles Multiple Benign | NA | Status: ACTIVE_NOT_RECRUITING